On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Katerina Politi

ResearcherPublications, citations & collaboration network

Katerina Politi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Katerina Politi have?

ScholarIQindexed works

Katerina Politi has 630 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Katerina Politi have?

ScholarIQcitation count

Katerina Politi has 20,772 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Katerina Politi?

ScholarIQh-index

Katerina Politi has an h-index of 55 in OpenAlex.

What is the i10-index of Katerina Politi?

ScholarIQi10-index

Katerina Politi has an i10-index of 106 in OpenAlex.

What is the ORCID of Katerina Politi?

ScholarIQorcid

The ORCID for Katerina Politi is on the source record.

What is the OpenAlex record for Katerina Politi?

ScholarIQopenalex

The OpenAlex for Katerina Politi is on the source record.

What are the most-cited papers on Katerina Politi?

ScholarIQmost cited works
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
Proceedings of the National Academy of Sciences. 20044,354 CitationsOPEN ACCESS
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
William Pao, Vincent A. Miller, Katerina Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, Harold Varmus
PLoS Medicine. 20053,538 CitationsOPEN ACCESS
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Scott Gettinger, Jungmin Choi, Katherine Hastings, Anna Truini, Ila Datar, Ryan Sowell, Anna Wurtz, Weilai Dong, Guoping Cai, Mary Ann Melnick, Victor Y. Du, Joseph Schlessinger, Sarah B. Goldberg, Anne C. Chiang, Miguel F. Sanmamed, Ignacio Melero, Jackeline Agorreta, Luis M. Montuenga, Richard P. Lifton, Soldano Ferrone, Paula Kavathas, David L. Rimm, Susan M. Kaech, Kurt A. Schalper, Roy S. Herbst, Katerina Politi
Cancer Discovery. 2017765 CitationsOPEN ACCESS
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren, Michael Tsabar, Michael S. Cuoco, Liat Amir-Zilberstein, Heidie Frisco Cabanos, Jan-Christian Hütter, Bomiao Hu, Pratiksha I. Thakore, Marcin Tabaka, Charles P. Fulco, William Colgan, Brandon M. Cuevas, Sara A. Hurvitz, Dennis J. Slamon, Amy Deik, Kerry A. Pierce, Clary B. Clish, Aaron N. Hata, Elma Zaganjor, Galit Lahav, Katerina Politi, Joan S. Brugge, Aviv Regev
Nature. 2021527 CitationsOPEN ACCESS
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Sarah B. Goldberg, Azeet Narayan, Adam J. Kole, Roy H. Decker, Jimmitti Teysir, Nicholas Carriero, Angela Lee, Roxanne Nemati, Sameer K. Nath, Shrikant Mane, Yanhong Deng, Nitin Sukumar, Daniel Zelterman, Daniel J. Boffa, Katerina Politi, Scott Gettinger, Lynn D. Wilson, Roy S. Herbst, Abhijit A. Patel
Clinical Cancer Research. 2018455 Citations

Related on ScholarIQ

470M+ articles · free account